Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$485.42 USD

485.42
904,979

+3.15 (0.65%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $485.43 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (171 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Here's Why You Should Hold on to Thermo Fisher (TMO) for Now

Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.

Sheraz Mian headshot

Making Sense of the Q3 Earnings Picture and Beyond

Recent updates on the revisions trends have been somewhat disconcerting, as you can see in the chart below that tracks the evolution of Q3 earnings growth expectations...

McKesson (MCK) Up 3.6% Since Last Earnings Report: Can It Continue?

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from its robust Distribution Solutions segment.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

McKesson (MCK) Earnings and Revenues Beat Estimates in Q1

McKesson's (MCK) fiscal first-quarter 2022 results benefit from strong performance across all segments.

McKesson (MCK) Q1 Earnings and Revenues Surpass Estimates

McKesson (MCK) delivered earnings and revenue surprises of 35.94% and 5.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for McKesson (MCK) This Earnings Season?

McKesson (MCK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Trina Mukherjee headshot

Medical Products' Aug 4 Earnings Roster: MCK, ABC & More

The Medical Product companies' second-quarter results are likely to reflect robust earnings and revenue growth on solid base business recovery.

McKesson (MCK) to Report Q1 Earnings: What's in the Offing?

McKesson's (MCK) fiscal first-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.

McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Indrajit Bandyopadhyay headshot

US States Get $26B Settlement Deal in Opioid Abuse Litigation

Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon.

McKesson (MCK) Soars 3.2%: Is Further Upside Left in the Stock?

McKesson (MCK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

McKesson (MCK) Enters Deal to Divest Some European Businesses

McKesson (MCK) to sell off some of its European ventures to streamline its business and prioritize investments in areas where it has better expertise.

Here's Why You Should Retain McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from its robust Distribution Solutions segment.

Should Value Investors Buy McKesson (MCK) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Xtrackers Russell US Multifactor ETF (DEUS) a Strong ETF Right Now?

Smart Beta ETF report for DEUS

Here's Why You Should Retain McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from its robust Distribution Solutions segment.

Strength Seen in McKesson (MCK): Can Its 6.8% Jump Turn into More Strength?

McKesson (MCK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

McKesson (MCK) Q4 Earnings Beat Estimates, Revenues Miss

McKesson's (MCK) fiscal fourth-quarter 2021 results benefit from strong performance at Medical-Surgical Solutions segment.

McKesson (MCK) Q4 Earnings Top Estimates

McKesson (MCK) delivered earnings and revenue surprises of 0.60% and -2.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Should You Buy McKesson (MCK) Ahead of Earnings?

McKesson (MCK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.